The Democratic Republic of Congo is currently managing an accelerating outbreak of the Bundibugyo strain of Ebola, which has resulted in over 400 fatalities and expanded into multiple provinces and neighboring Uganda.

剛果民主共和國目前正在處理一次加速擴散的 Bundibugyo 埃博拉病毒爆發，已導致超過 400 人死亡，並擴散至多個省份及鄰近的烏干達。

The current epidemiological crisis, declared on May 15, is characterized by a case fatality rate exceeding 31%, although the World Health Organization (WHO) posits that the actual mortality figure may be higher due to unverified deaths preceding the official declaration. The Ituri province serves as the primary epicenter, accounting for over 83% of fatalities, while transmission has extended to North Kivu, South Kivu, Haut-Uele, and Tshopo. Notably, the virus has reached Kisangani, a high-density urban center, following the clandestine transport of an infected decedent. This incident underscores the heightened risk associated with traditional burial practices and the continued contagiousness of the virus post-mortem.

此次於 5 月 15 日宣布的流行病危機，其特徵為病死率超過 31%，儘管世界衛生組織 (WHO) 認為，由於在正式宣布前存在未經核實的死亡個案，實際死亡數字可能更高。伊圖賴省為主要疫區，佔死亡人數 83% 以上，而傳播已延伸至北基伍省、南基伍省、上烏埃萊省及措波省。值得注意的是，由於秘密運送染疫死者，該病毒已傳入高密度城市中心基桑加尼。此事件突顯了傳統葬禮習俗相關的高風險，以及病毒在死後仍具傳染力。

Institutional responses have focused on the deployment of financial and technical resources. President Felix Tshisekedi has initiated a $319 million national containment strategy, complemented by $910 million in international donor pledges. To address the absence of an approved vaccine for the Bundibugyo variant, the WHO has commenced clinical trials for the antiviral remdesivir and the monoclonal antibody MBP134. Furthermore, the WHO has implemented an Emergency Use Listing (EUL) for the first molecular diagnostic test for the Bundibugyo virus, facilitating a transition from limited testing in Kinshasa and Goma to a network of ten laboratories capable of processing over 2,000 tests daily. International cooperation is further evidenced by China's dispatch of a second medical expert team specializing in epidemiology and quarantine.

官方應對重點在於部署資金與技術資源。總統 Felix Tshisekedi 啟動了一項 3.19 億美元的國家遏制策略，並輔以國際捐助者承諾的 9.1 億美元。針對 Bundibugyo 變異株缺乏核准疫苗的問題，WHO 已對抗病毒藥物 remdesivir 及單克隆抗體 MBP134 展開臨床試驗。此外，WHO 為 Bundibugyo 病毒的首個分子診斷測試實施了緊急使用清單 (EUL)，使測試從僅限於金沙莎與戈馬，轉型為一個由十個實驗室組成的網絡，每日可處理超過 2,000 個測試。中國派遣第二支專精於流行病學與隔離的醫療專家隊，進一步證明了國際合作。

Containment efforts are significantly impeded by systemic instability and socio-political friction. The convergence of armed conflict, population displacement, and a deficit in essential medical supplies—including protective equipment and chlorine—has compromised the efficacy of health interventions. Public mistrust has manifested in violent confrontations, specifically in the Nia-Nia health zone, where the destruction of a treatment center and the escape of isolated patients occurred. These challenges are exacerbated by local denials of the virus's existence and allegations that international aid organizations are motivated by financial gain.

遏制工作受到系統性不穩定與社會政治摩擦的嚴重阻礙。武裝衝突、人口流離失所以及基本醫療物資（包括防護設備與氯）的短缺，共同削弱了醫療干預的成效。公眾不信任已演變為暴力衝突，特別是在 Nia-Nia 衛生區，發生了治療中心被毀及隔離患者逃離的事件。由於當地否認病毒存在，並指控國際援助組織出於金錢利益，使這些挑戰 further 惡化。

The outbreak remains in an expansionary phase, necessitating the rapid validation of diagnostic tools and the successful conclusion of therapeutic trials to mitigate further regional transmission.

此次爆發仍處於擴散階段，因此需要快速驗證診斷工具並成功完成治療試驗，以減輕進一步的區域傳播風險。